Prot# NTI 0302: A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptomas Associated with Peritumoral Brain Edema in Patients with Primary Malignant Glioma

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/26/0610/1/11

Funding

  • Neurobiological Technologies, Inc. (NTI 0302)
  • Celtic Pharma Development Services Bermuda Ltd. (NTI 0302)